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COMPARISON OF ApoE-RELATED BRAIN CONNECTIVITY 
DIFFERENCES IN EMCI AND NORMAL AGING POPULATIONS: 
AN fMRI STUDY 
FAYE FITZGERALD McKENNA 
ABSTRACT 
In this study, we used resting-state functional magnetic resonance imaging (fMRI) 
scans from subjects with early mild cognitive impairment (EMCI) and control subjects to 
study functional network connectivity.  The scans were acquired by the Alzheimer’s 
Disease Neuroscience Initiative (ADNI).  We used genetic data from the ADNI database 
to further subdivide the EMCI and control groups into genotype groups with or without 
the ApoE4 allele.  ROI-to-ROI resting-state functional connectivity was measured using 
Freesurfer and the Functional Connectivity Toolbox for Matlab (CONN). In our analysis, 
we compared whole-brain ROI connectivity strength and ROI-to-ROI functional network 
connectivity strength between EMCI, control and genotype subject groups.  We found 
that the ROI network properties were disrupted in EMCI and ApoE4-containing groups.  
Notably, we show that (1) EMCI disrupts functional connectivity strength in many areas; 
(2) the ApoE4 allele disrupts functional connectivity strength in similar areas to EMCI; 
and (3) the differences in functional connectivity between groups shows a multifactor 
contribution to functional network dysfunction along the trajectory leading to dementia.  
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INTRODUCTION 
 
Alzheimer’s disease (AD) is one of the most common neurodegenerative diseases 
in the world, and is clinically characterized by memory impairment and more extensive 
cognitive impairments at later stages (Petersen et al., 1999). Early mild cognitive 
impairment (EMCI) is thought of as the mildest symptomatic phase of AD and a 
transitional state between normal aging and AD (Mueller et al., 2005). About half of 
EMCI patients develop AD in 3 to 5 years (Petersen et al., 2001).  The major focus of 
EMCI research has been to try to determine who will develop AD, and the contributing 
factors (Mueller et al., 2005). It is hypothesized that AD pathology is multifactorial, and 
cognitive ability can vary greatly across healthy aging and clinically diagnosed people 
(Buckner, 2004).  There are several distinct factors known to contribute to AD, one of the 
most significant is the Apolipoprotein E allele 4 (ApoE4) (Buckner, 2004).  The ApoE4 
allele is the best-established genetic risk factor for sporadic AD, and it increases the risk 
of developing AD 3 to 15 times (Mahley et al., 2006). There is increasing evidence that 
ApoE4 modulates brain activity of both normal and AD patients as measured by fMRI 
(Machulda et al., 2011). 
In the current study we sampled resting-state fMRI scans of EMCI patients with 
matched controls from the ADNI database to investigate the hypothesis that EMCI is 
characterized by disruptions in functional connectivity brain networks associated with 
memory and cognitive functioning.  We also evaluated the effects of genotype on 
functional network connectivity by comparing ROI network connections in all subjects 
with and without the ApoE4 genotype.  In doing this, we examined how the ApoE4 
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genetic predisposition contributes to brain dysfunction, and compares it to the pathology 
observed of the EMCI phenotype.  
Most information about how AD and its earlier stages affect brain morphometry 
come from post-mortem ex-vivo analysis and structural MRI (Buckner, 2004).  Resting 
state-fMRI (rsfMRI) is a popular and reliable tool for studying functional connectivity, 
which has been successfully used to investigate aging and dementia (Sanz-Arigita et al., 
2010; Sheline et al., 2004; Wang et al., 2007).  Abnormal functional connectivity patterns 
have been found to be a potential biomarker for the diagnosis of AD and EMCI (Greicius 
et al., 2004; Wang, 2009; Wang et al., 2007).    
Functional MRI works by measuring the spatio-temporal correlations between 
distinct regions of the cerebral cortex by quantifying the regional cerebral blood flow 
(rCBF) in regions of interest (ROI) and across the brain (Friston, 1993). These 
fluctuations in blood flow and oxygenation are quantified in the blood oxygen level 
dependent (BOLD) fMRI signal, a secondary marker of neural activity (Biswall, 1995). 
Resting state fMRI extracts the spontaneous activity of the resting brain, where low-
frequency fluctuations (LFFs) in the fMRI time series occur between functionally related 
and spatially distinct brain regions (Biswall, 1995). A primary method used to investigate 
the functional connectivity of specific brain regions is by seed-driven resting state 
functional connectivity (RS-FC) analysis (Fox et al., 2005). In this study we use the 
NITRC Functional Connectivity Toolbox (CONN) for Matlab, created by MIT to 
implement the seed-driven ROI-to-ROI RSFC analysis strategy.    
The neural basis underlying the functional damage in EMCI is not yet fully 
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understood. Previous fMRI studies have revealed that the cognitive function deficits in 
AD and its earlier stages could be due to abnormalities in the connectivity between brain 
areas (Supekar et al., 2008). Recently, multimodal imaging studies have provided 
evidence that AD is a disconnection syndrome, but there is not a convergence on the 
network pattern (Delbeuck et al., 2003). Previous research points to there being altered 
functioning in the hippocampus surrounding brain regions crucial to memory and higher-
level cognition (Greicius et al., 2004). The disconnection interpretation of dementia 
pathology has been strengthened by its complex symptomatology (Delbeuck et al., 2004).  
It is less probable that dementia is a result of pathophysiology in one neuronal system, 
but instead a consequence of an alteration in the brain’s connectivity between several 
neuronal systems (Delbeuck et al., 2004).  Through rs-fMRI connectivity analysis, this 
study examined the evidence that points to AD, in its earlier form of EMCI, as being a 
disconnection syndrome.  
MATERIALS AND METHODS 
Subjects 
The data for this study was chosen from the Alzheimer’s Disease Neuroscience 
Initiative (ADNI) public database (www.loni.ucla.edu/ADNI). The data was screened for 
subjects who were either EMCI or control, had base-line resting-state fMRI scans, and 
were in the ADNI2 or ADNIGO phases at the time this study started. ADNIGO and 
ADNI2 are the two latest stages in the ADNI study and include the EMCI subject 
grouping. Out of the initial 44-screened subjects 4 were omitted due to anatomical 
abnormalities in their MRI scans, and 4 were omitted because of missing information. 
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This left 36 subjects selected from the database (N=36), 18 EMCI and 18 matched 
control subjects.  
Subjects were matched based on age, sex, education and MMSE score (See table 
1). R-Studio was used to run t-tests and ensure that there was no difference in age, sex, 
education, MMSE and genotype in between Control and EMCI subject groups (see table 
1) (R, 2014).  The subject’s average age =69.72 years old with 13.21 SD, mode age =63 
years, median age =71.2 years (see table 2).  The subject’s average MMSE score =28.72 
with 1.23 SD point, mode MMSE score =30, median MMSE score =29 (see table 2) . The 
subject’s average education= 15.78 years with 2.59 years of SD, the mode education =16 
years, the median education =16 years (see table 2).  Out of the subjects 10 were men, 26 
were women equally distributed as EMCI and Control subjects (see table 2).   
There were 14 subjects with the ApoE 4 gene, 6 were control subjects and 8 were 
EMCI subjects (See table 2).  There were 22 subjects with out an ApoE 4 gene, 12 were 
control subjects and 10 were EMCI subjects (see table 2).  The subjects with the ApoE4 
allele had an average age= 70.21 years with a SD of 3.79 years, median age= 70.21 years.  
The subjects with out the ApoE4 allele had an average age =72.77 years with a SD of 6.4 
years, a median age =72.5 years.  The subjects with the ApoE4 allele had an average 
MMSE score =29 points with a SD of 1.37, a mode MMSE =30, a median MMSE =29.  
The subjects with out the ApoE4 allele had an average MMSE score =28.68 with a SD of 
1.17, a mode MMSE score= 29, a median score =29.  The subjects with the ApoE4 allele 
had an average education =15.85 years with SD of 2.61 years, a mode education =16, 
median education =16.36 years.   The subjects with out the ApoE4 allele had an average 
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education= 15.6 years with a SD of 2.53 years, a mode education =16, median education 
=15.4 years.   
Table 1: EMCI/Control Matching Statistics.  
Variable t df p-value 
Genotype  0.8092 33.912 0.424 
MMSE Score -0.2667 31.523 0.7914 
Education  -0.2542 33.998 0.8008 
Age  -0.0615 31.354 0.9514 
Sex  0.3523 33.911 0.7268 
T-tests were run to show there are no significant differences in genotype, MMSE score, 
education, age or sex between the EMCI and control subject groups. 
 
Table 2: Statistics.  
Measures All  Controls EMCI W/E4 W/O E4 
N 36 18 18 14 22 
Mean Age (yrs) 69.72 67.61  71.83 70.21 72.77 
SD Age (yrs) 13.21 17.55 6.47 3.79 6.4 
Median Age (yrs) 71.2 71.35 71.45 70.8 72.5 
Mean MMSE score 28.72 28.67 28.78 28.79 28.68 
SD MMSE score 1.23 1.41 1.06 1.37 1.17 
Median MMSE 
score 
29 29 29 29 29 
Mean Ed (yrs) 15.78 15.67 15.89 15.85 15.6 
SD Ed (yrs) 2.59 2.61 2.63 2.61 2.53 
Median Ed (yrs) 16 16 16 16 16 
Male 10 5 5 4 6 
Female 26 13 13 8 18 
Shows all statistics for EMCI/Control groups and W/ W/o APOE4 groups. 
Demographics 
All subjects in the ADNI program complete a battery of neuropsychological tests 
and demographic information (Petersen, 2013).  Based on cognitive tests, the subjects 
were classified by the ADNI clinical score as: (a) normal controls with normal cognition 
and memory, Mini Mental Status Exam (MMSE) between 24-30, Clinical Dementia 
Rating (CDR) 0; (b) EMCI with a memory complaint verified by a study partner, 
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abnormal memory function documented by scoring below the education adjusted cutoff 
on the Logical Memory II subscale from the Wechsler Memory Scale-Revised (Roid et 
al., 2007), MMSE score between 24 and 30, CDR 0.5, memory box score at least 0.5, 
absence of dementia observed by physician at time of screening visit, preserved activities 
of daily living; (c) amnestic MCI with memory complaint verified by a study partner, 
memory loss measured by education-adjusted performance on the Logical Memory II 
subscale of the Wechsler Memory Scale-Revised (Roid et al., 2007), memory box score 
at least 0.5, MMSE between 24 and 30, CDR 0.5, absence of dementia observed by 
physician at time of screening visit, preserved activities of daily living; (d) probably AD 
with memory complaint validated by study partner, abnormal memory function for age 
and education level, impaired activities of daily living, reduced cognition, CDR>0.5, 
MMSE between 20-26 (Petersen, 2013). For this study only control and EMCI data was 
used. 
All subjects recruited were also screened for: age between 55-90, a Modified 
Hachinski score of less than or equal to 4, stable permitted medications, a Geriatric 
Depression Scale less than 6, adequate visual and auditory acuity for neuropsychological 
testing, good general health with no disease expected to interfere with the study, six grade 
education or good work history, English or Spanish fluency, and willingness to 
participate in all parts of the data collection (Petersen, 2013).   
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Alzheimer’s Disease Neuroscience Initiative  
 The ADNI is a non-randomized natural history non-treatment study (Petersen, 
2013).  ADNI began in October of 2004 and has followed AD at earlier stages, and with 
biomarkers Petersen, 2013).  So far ADNI has documented thousands of subjects in its 
open-source database (Petersen, 2013).  Clinical data collection and monitoring are 
standardized with ADNI Core Site operating procedures (Petersen, 2013).  The study 
follows individuals longitudinally (Petersen, 2013).  For this study only baseline 
measures where used to each subject.  
Neuropsychological Testing 
 The tests and scales used in the ADNI study were selected because they represent 
domains of interest in the patient population, adequately sample cognitive ability in the 
range of subjects, can measure longitudinal change, there are no floor or ceiling effects, 
have been tested previously (Petersen, 2013).  For the categorization of subjects and 
screening the following tests and scales were used: CDR memory, CDR problem solving 
and judgment, MMSE, Montreal Cognitive Assessment (MoCA), Everyday Cognition 
(ECog), Clock Drawing Test, Activities of Daily Living FAQ, Neuropsychiatric 
Inventory (NPIQ), Geriatric Depression Scale, Concomitant Medications, Vital Signs, 
and Diagnostic Summary (Petersen, 2013). We analyzed the cognitive MMSE scores 
from the cognitive and psychological tests taken at baseline in order to match the 
subjects.    
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Genetic Testing 
 Whole blood samples were collected at baseline for all subjects for ApoE 
genotyping by the ADNI.  A single 10mL EDTA tube of whole blood was sent overnight 
on the day of collection to the National Cell Repository for AD (NCRAD) for genotyping 
(Peterson, 2013). For ADNI2 and ADNIGO genotyping was performed on 85 genomic 
DNAs using the Illumina Human Omni Express Bead Chip, which contains 730,525 SNP 
markers, according to the manufacturer’s protocols (Petersen, 2013).  The epsilon 4 allele 
of ApoE is the strongest known genetic risk factor for AD with a two to twelve-fold 
increase risk for AD in people with one or two copies of the allele (Mahley et al., 2006).  
For this study we grouped the subjects into two groups, with and without the ApoE 
epsilon 4 allele.  There were 22 subjects without a copy of the ApoE 4 allele, and 14 
subjects with at least one copy of the ApoE 4 allele.  Out of the 14 subjects with at lease 
one copy of the ApoE 4 allele 8 were EMCI subjects, and 6 were control subjects (see 
table 1 and 2).   
MRI Data Acquisition  
All subjects were scanned on a 3T Philips scanner, either an Intera or Achieva 
model at a participating ADNI research site.  For each subject the ADNI MRI protocol 
obtained a structural MRI MPRAGE scan with T1-weighting; 1.2 slice thickness, a 
sagittal acquisition plane. For each subject the ADNI MRI protocol also obtained a T2* 
fMRI resting-state scan with 3.3 slice thickness, 30.0 TE, 3000 TR (Petersen, 2013).  
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FreeSurfer Analysis 
All of the subject’s original raw MRI scans downloaded from the ADNI database 
in DICOM format and were processed using FreeSurfer 5.3.  FreeSurfer is a software 
application developed by the Martinos Center for Biomedical Imaging by the Laboratory 
for Computational Neuroimaging (FreeSurfer Wiki, 2014).  FreeSurfer’s package of tools 
for visualization of structural and functional brain data was used to analyze this data set.  
The FreeSurfer ‘recon-all’ tool, which is a fully automated structural imaging stream that 
runs 30 steps was used to execute all of the volumes and surface processing pipelines 
(FreeSurfer Wiki, 2014). The FreeSurfer recon-all pipeline was used for: motion 
correction, intensity normalization, talairach transformation, skull stripping, segmentation 
of the cortex, subcortex and white matter, to generate surfaces and create spherical and 
flattened representations.  There are three automated atlases that were used in 
FreeSurfer’s recon-all script for cortical segmentation and labeling: Desikan-Killiany, 
Destrieux and DKT40 atlas.  In this study we used the Desikan-Killiany atlas. 
The Freesurfer GUI Freeview was used to model the subject’s brain scans in 2 
dimensional and 3 dimensional space in order to inspect the recon-all processing output.  
The topical defects that were fixed with Freeview were white matter and gray matter 
subcortical segmentation, and the corresponding processing step in the recon-all pipeline 
were re-run for correction. 
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CONN Toolbox  
Figure 1: CONN processing steps (Whitfield-Gabrieli and Nieto-Castanon, 2013) 
 
Resting state DICOM scans were converted to Nifti files with MRIcron’s dcm2nii 
in order to be processed in The Functional Connectivity Toolbox 2014 (CONN). CONN 
is a Matlab-based cross-platform software that was used to compute, analyze the 
functional connectivity of fMRI (Whitfield-Gabrieli and Nieto-Castanon, 2013).  The 
CONN toolbox utilized Matlab version 2012 and SPM8 to process the resting-state fMRI 
scans into ROI-to-ROI connectivity matrices, test hypotheses and visualize data 
(Whitfield-Gabrieli and Nieto-Castanon, 2013). CONN uses a seed-driven RSFC analysis 
strategy, where the pearson’s correlation coefficient is calculated between the seed time 
course and the time course of all other voxels (Whitfield-Gabrieli and Nieto-Castanon, 
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2013). After, the correlation coefficients were converted to normally distributed scores 
using Fisher’s transformation to allow for second-level General Linear Model analysis 
(Whitfield-Gabrieli and Nieto-Castanon, 2013). The correlation maps depend on the 
specific location of the seed so that functionally and anatomically heterogeneous ROI are 
dissociated in order to delineate functional anatomy in the brain by sharp transitions in 
correlation patterns that signal functional boundaries across the cortex (Whitfield-
Gabrieli and Nieto-Castanon, 2013).  
 The subject’s preprocessed MPRAGE scans were imported into CONN, and used 
alongside the resting state scans. CONN used CompCor strategy for spatial and temporal 
preprocessing to define and remove confounds in the BOLD signal to prevent the impact 
of physiological noise factors and motion in the data (Behzadi et al., 2007).   The 
CompCor strategy is unique because it is more flexible in its characterization of noise 
(Behzadi et al., 2007).  CompCor models the influence of noise as a voxel-specific linear 
combination of multiple empirically estimated noise sources, which are estimated from 
the variability in the BOLD responses within noise ROIs (Behzadi et al., 2007). This is 
important for the removal of fMRI noise because cardiac and respiratory effects do not 
have a common spatial distribution in their effects.  The removal of this richer 
characterization of the range of voxel-specific noise effects and additional movement 
along with temporal filtering and windowing the BOLD signal at each voxel protects 
against confounds in RS-FC without introducing artifactual biases in connectivity 
measures.  
CONN created subject-specific ROI files for 105 ROIs and registered them to the 
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subject space, which included four FOX ROIs and all the Brodmann areas (see table 6). 
The 99 ROI were used as the seeds of interest for whole-brain subject-specific ROI-ROI 
connectivity analyses.  
Table 3: ROI list.  
Region  
BA.1 (L). Primary Somatosensory 
Cortex  
BA.35 (L). Perirhinal cortex  
BA.1 (R). Primary Somatosensory 
Cortex  
BA.35 (R). Perirhinal cortex  
BA.10 (L). Anterior Prefrontal Cortex  BA.36 (L). Parahippocampal cortex  
BA.10 (R). Anterior Prefrontal Cortex  BA.36 (R). Parahippocampal cortex  
BA.11 (L). Orbitofrontal Cortex  BA.37 (L). Fusiform gyrus  
BA.11 (R). Orbitofrontal Cortex  BA.37 (R). Fusiform gyrus  
BA.13 (L). Insular Cortex  BA.38 (L). Temporopolar Area  
BA.13 (R). Insular Cortex  BA.38 (R). Temporopolar Area  
BA.17 (L). Primary Visual Cortex  BA.39 (L). Angular gyrus  
BA.17 (R). Primary Visual Cortex  BA.39 (R). Angular gyrus  
BA.18 (L). Secondary Visual Cortex  BA.4 (L). Primary Motor Cortex  
BA.18 (R). Secondary Visual Cortex  BA.4 (R). Primary Motor Cortex  
BA.19 (L). Associative Visual Cortex  BA.40 (L). Supramarginal Gyrus  
BA.19 (R). Associative Visual Cortex  BA.40 (R). Supramarginal Gyrus  
BA.2 (L). Primary Somatosensory 
Cortex  
BA.41 (L). Primary Auditory Cortex  
BA.2 (R). Primary Somatosensory 
Cortex  
BA.41 (R). Primary Auditory Cortex  
BA.20 (L). Inferior Temporal Gyrus  BA.42 (L). Primary Auditory Cortex  
BA.20 (R). Inferior Temporal Gyrus  BA.42 (R). Primary Auditory Cortex  
BA.21 (L). Middle Temporal Gyrus  BA.43 (L). Subcentral Area  
BA.21 (R). Middle Temporal Gyrus  BA.43 (R). Subcentral Area  
BA.22 (L). Superior Temporal Gyrus  BA.44 (L). IFC pars opercularis  
BA.22 (R). Superior Temporal Gyrus  BA.44 (R). IFC pars opercularis  
BA.23 (L). Ventral Posterior Cingulate 
Cortex  
BA.45 (L). IFC pars triangularis  
BA.23 (R). Ventral Posterior Cingulate 
Cortex  
BA.45 (R). IFC pars triangularis  
BA.24 (L). Ventral Anterior Cingulate 
Cortex  
BA.46 (L). Dorsolateral Prefrontal 
Cortex  
BA.24 (R). Ventral Anterior Cingulate 
Cortex  
BA.46 (R). Dorsolateral Prefrontal 
Cortex  
BA.25 (L). Subgenual cortex  BA.47 (L). Inferior Prefrontal Gyrus  
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BA.25 (R). Subgenual cortex  BA.47 (R). Inferior Prefrontal Gyrus  
BA.27 (L). Piriform Cortex  BA.5 (L). Somatosensory Association 
Cortex  
BA.27 (R). Piriform Cortex  BA.5 (R). Somatosensory Association 
Cortex  
BA.28 (L). Posterior Entorhinal Cortex  BA.6 (L). Premotor Cortex  
BA.28 (R). Posterior Entorhinal Cortex  BA.6 (R). Premotor Cortex  
BA.29 (L). Retrosplenial Cingulate 
Cortex  
BA.7 (L). Somatosensory Association 
Cortex  
BA.29 (R). Retrosplenial Cingulate 
Cortex  
BA.7 (R). Somatosensory Association 
Cortex  
BA.3 (L). Primary Somatosensory 
Cortex  
BA.8 (L). Dorsal Frontal Cortex  
BA.3 (R). Primary Somatosensory 
Cortex  
BA.8 (R). Dorsal Frontal Cortex  
BA.30 (L). Cingulate Cortex  BA.9 (L). Dorsolateral Prefrontal Cortex  
BA.30 (R). Cingulate Cortex  BA.9 (R). Dorsolateral Prefrontal Cortex  
BA.31 (L). Dorsal Posterior Cingulate 
Cortex  
Precuneus (PCC) (0,-56,28)  
BA.31 (R). Dorsal Posterior Cingulate 
Cortex  
Right Inferior Parietal Lobe (RLP) (48,-
60,38)  
BA.32 (L). Dorsal anterior Cingulate 
Cortex  
Left Inferior Parietal Lobe (LLP) (-42,-
68,38)  
BA.32 (R). Dorsal anterior Cingulate 
Cortex  
Med Prefrontal Cortex (MPFC) (0,54,-8)  
BA.33 (L). Anterior Cingulate Cortex  Right Posterior Sup Temp Gyrus (60,-
30,24)  
BA.33 (R). Anterior Cingulate Cortex  Right Anterior Sup Temp Gyrus (54,8,-
2)  
BA.34 (L). Anterior Entorhinal Cortex  Cingulate Gyrus (0,6,40)  
BA.34 (R). Anterior Entorhinal Cortex  Right Superior Frontal Gyrus (30,22,52)  
 Left Superior Frontal Gyrus (-28,22,52)  
 Left Posterior Sup Temp Gyrus (-60,-
30,20)  
 Left Anterior Sup Temp Gyrus (-44,4,-
4)  
105 ROI (47 in each hemisphere), more details about cerebral parcellation can be found 
in [Whitfield-Gabrieli and Nieto-Castanon, 2013].   
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Figure 2: CONN Time Series Equation 
 
Statistical Analysis 
Functional connectivity measures were computed between the created subject-
specific seed areas for ROI-to-ROI analysis and to create ROI-to-ROI connectivity 
matrices (see figure 1).  The average BOLD times series was computed across all the 
voxels within each ROI (See figure 2).  First, the toolbox used a linear measure of 
functional connectivity between bivariate correlation and bivariate-regression 
coefficients, with their associated multivariate measures of semipartial-correlation and 
multivariate-regression coefficients to calculate functional connectivity (Whitfield-
Gabrieli and Nieto-Castanon, 2013).  The bivariate correlation and regression coefficients 
measure the level of linear association of the BOLD time series between each pair of 
sources in isolation (Whitfield-Gabrieli and Nieto-Castanon, 2013).  On the other hand, 
the semi-partial correlation and multivariate regression coefficients considered multiple 
sources simultaneously to estimate the unique contribution of each source using the linear 
model (Whitfield-Gabrieli and Nieto-Castanon, 2013).  For bivariate and semipartial 
correlation analyses the effect sizes represent the correlation coefficients, or the 
percentage of the target BOLD signal variance explained by each source (Whitfield-
Gabrieli and Nieto-Castanon, 2013).  The bivariate and multivariate regression analysis 
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shows effect size as a percentage change in BOLD activity at each target associated with 
a 1% change of BOLD activity at each source ROI (Whitfield-Gabrieli and Nieto-
Castanon, 2013).  Before the second-level between-subjects analysis a Fisher 
transformation was applied to all bivariate and semi-partial correlation measures to 
improve normality assumptions (Whitfield-Gabrieli and Nieto-Castanon, 2013).   
CONN computed a complete voxel-to-voxel functional correlation matrix for 
each subject, along with several voxel-level measures of functional connectivity directly 
from that correlation matrix (Whitfield-Gabrieli and Nieto-Castanon, 2013).  The voxel-
to-voxel bivariate correlation coefficient was calculated through the BOLD time series at 
every voxel within a priori gray matter mask and characterized by its eigenvectors and 
associated eigenvalues to minimize storage (Whitfield-Gabrieli and Nieto-Castanon, 
2013).  The associated voxel-level measures were integrated local correlation (ILC), 
radial correlation contrast (RCC), intrinsic connectivity contrast (ICC), and radial 
similarity contrast (RSC) (Whitfield-Gabrieli and Nieto-Castanon, 2013).  The resting 
state data was treated like a special case of task-specific analysis where only one 
condition spans the entire scanner acquisition length (Whitfield-Gabrieli and Nieto-
Castanon, 2013).  The ILC characterizes the average local connectivity between each 
voxel and its neighbors (Whitfield-Gabrieli and Nieto-Castanon, 2013).  The RCC 
characterizes the spatial asymmetry of the local connectivity pattern between each voxel 
and its neighbors (Whitfield-Gabrieli and Nieto-Castanon, 2013).  ICC and RSC are 
novel measures similar to ILC and RCC, but that characterize the global connectivity 
pattern between each voxel and the rest of the brain (Whitfield-Gabrieli and Nieto-
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Castanon, 2013).  The ICC characterizes the strength of the global connectivity pattern 
between each voxel and the rest of the brain and the RSC characterizes the global 
similarity between the connectivity patterns of neighboring voxels (Whitfield-Gabrieli 
and Nieto-Castanon, 2013).   
After each subject had ROI-to-ROI connectivity matrices, seed-to-voxel 
connectivity maps and voxel-to-voxel fcMRI measures they were entered into CONN’s 
second level general linear model that includes the selected terms as regressors to get 
population-level results. ROI-level analyses were evaluated through F- or Wilks lambda 
statistics depending on the dimensionality of the within and between subjects contrasts. 
Connectivity contrast effect size between all ROI sources was calculated alongside T,F,X 
values, uncorrected p-values and FDR-corrected p-values for each specified second-level 
analysis. The F-test was used to calculate the multivariate connectivity strength for each 
seed and seed/network-level thresholds.  
We tested: the EMCI versus control subject group contrast, the ApoE gene high 
versus low risk group interaction, The subjects group versus ApoE gene group 
interaction, the EMCI subjects versus ApoE high versus low risk group interaction, and 
the control subjects versus ApoE high versus low risk group interaction.  The significance 
of ROI-to-ROI connection was determined through the false positive control false 
discovery rate (FDR)-corrected p-values with a chi-squared test with two-sided 
inferences.  This is the appropriate way to test the hypothesis of the entire set of ROIs 
without a priori (Whitfield-Gabrieli and Nieto-Castanon, 2013).  This false-positive 
control test was implemented through both a voxel-level height threshold and a cluster-
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level extent threshold defined by the uncorrected p-values.  
The desired p-value thresholds were determined by which one showed only the 
strongest and most significant connections. The EMCI vs. control group connectivity 
analysis was thresholded to .00001 for ROI-ROI and .00001 for seed ROI tests. The 
ApoE genetic group connectivity analysis was thresholded to at .00001 for ROI-ROI and 
.00001 for seed ROI tests.  The genetic vs. subject groups connectivity analysis was 
thresholded to .00001 for ROI-ROI and .00001 for seed ROI tests.   
RESULTS 
 Demographic characteristics and neuropsychological scores are shown in Tables 
1-5.  No significant differences in gender, age and education level were noted between 
the experimental groups (Table 1). The EMCI group had significantly less ROI 
connectivity notably in the medial prefrontal cortex region, medial temporal lobe areas, 
surrounding hippocampal areas and primary visual areas in the medial visual network 
(see figures 1, 2,3). The EMCI and matched-control subjects with high-risk ApoE E4 
genotype had less connectivity in the medial temporal lobe areas, surrounding 
hippocampal areas and primary visual areas in the medial visual network (see figures 
4,5,6).  The subject group x genotype group analysis revealed that EMCI subjects with 
the ApoE E4 genotype had less connectivity also in the medial temporal lobe areas, 
surrounding hippocampal areas and primary visual areas in the medial visual network 
(see figures 7,8,9).   
  
	  	   18 
Subject Group Differences 
 There are significant differences in brain connectivity between the EMCI and 
control subjects.  Control individuals had significantly stronger network connections 
notably in 10 ROI networks at the highest .00001 FDR-p value threshold for both seed 
level threshold and network level threshold (see table 7, Figure ).  Control individuals had 
16 significantly stronger ROI-ROI specific connections (see table 8). No ROI or ROI-
ROI connection strength was more significant in EMCI than in control subjects at the 
significant threshold.   
Table 4: Group-Normal vs. EMCI 
ROI Area Stats Intensity Size P-FDR value 
P-Unc 
value 
17L Left primary visual 
cortex X(16)=70.22 560.66 6 0.0000 0.0000 
18R Right Inferior temporal 
gyrus X(16)=69.76 585.80 11 0.0000 0.0000 
85 Precuneus  X(16)=66.46 491.91 10 0.0000 0.0000 
18L Left secondary visual 
cortex X(16)=65.78 695.07 11 0.0000 0.0000 
19L Left Associative visual 
cortex X(16)=65.18 680.48 18 0.0000 0.0000 
29R Right retrosplenial 
cingulate cortex X(16)=62.56 378.51 6 0.0000 0.0000 
17R Right primary visual 
cortex X(16)=62.33 465.49 8 0.0000 0.0000 
31L Left dorsal posterior 
cingulate cortex X(16)=59.49 446.99 12 0.0000 0.0000 
19R Right associative visual 
cortex X(16) =59.47 508.00 12 0.0000 0.0000 
32R Left dorsal anterior 
cingulate cortex X(16) =59.11    254.61 9 0.0000 0.0000 
The More Significantly Connected Regions in Control versus EMCI Subjects. In this 
table we only included ROI that were more significantly connected at a .00001 two-sided 
FDR-p value. 
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Table 5: Group- Normal vs. EMCI connections 
ROI Area Strength P-unc value  
P-FDR 
value 
17L-18L L Primary Visual Cortex- L Secondary Visual Cortex F(2)(34) = 186.91 0.0000 0.0000 
18L-19L L Secondary Visual Cortex- L Associative Visual Cortex F(2)(34) = 139.21 0.0000 0.0000 
29R-28L 
R Retrosplenial Cingulate 
Cortex- L Posterior Entorhinal 
Cortex 
F(2)(34) = 138.84 0.0000 0.0000 
17R-18R R Primary Visual Cortex- R Secondary Visual Cortex F(2)(34) = 113.24 0.0000 0.0000 
18R-18L R &L Secondary Visual Cortex F(2)(34) = 108.70 0.0000 0.0000 
17R-17L R & L Primary Visual Cortex F(2)(34) = 103.37 0.0000 0.0000 
17L-18R L Primary Visual Cortex-  R Secondary Visual Cortex F(2)(34) = 100.74 0.0000 0.0000 
17L-19L L Primary Visual Cortex- L Associative Visual Cortex F(2)(34) = 90.96 0.0000 0.0000 
31L-31R R&L Dorsal Posterior Cingulate Cortex F(2)(34) = 77.83 0.0000 0.0000 
19R-18R R Associative Visual Cortex- R Secondary Visual Cortex F(2)(34) = 76.41   0.0000 0.0000 
(85)-PCC Precuneus- Posterior Cingulate Cortex F(2)(34) = 71.72 0.0000 0.0000 
17R-19R R Primary Visual Cortex- R Associative Visual Cortex F(2)(34) = 69.78 0.0000 0.0000 
31L-PCC 
L Dorsal Posterior Cingulate 
Cortex-Posterior Cingulate 
Cortex 
F(2)(34) = 68.01 0.0000 0.0000 
18L-17R L Secondary Visual Cortex -R Primary Visual Cortex F(2)(34) = 64.55 0.0000 0.0000 
29R-(85) R Retrosplenial Cingulate Cortex- Precuneus F(2)(34) = 64.39 0.0000 0.0000 
29R-30L R Retrosplenial Cingulate Cortex-L Cingulate Cortex F(2)(34) = 64.25 0.0000 0.0000 
The More Significant ROI-ROI connections in Control vs. EMCI Subjects. In this 
table we only included ROI-ROI connections that were more significantly connected at a 
.00001 two-sided FDR-p value. 
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Figure 3: Superior, Inferior, Right, Left, Posterior View Control > EMCI 
Connectivity: Significant ROI, and ROI-ROI Connection in Control versus EMCI 
subject group.  Red to green = more to less significant. 
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Figure 4: 2D Axial ROI-Labeled, Control > EMCI Connectivity: Significant ROI, 
and ROI-ROI Connection in Control versus EMCI subject group.  Red to green = more to 
less significant. 
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Gene Group Differences 
There were significant differences in brain connectivity between subjects with 
variance in ApoE expression.  The low risk gene group, who did not have a copy of the 
E4 ApoE allele, had stronger ROI connectivity in 7 ROI (see table 9). Low-risk gene 
individuals had 29 significantly stronger ROI-ROI specific connections (see table 10). 
The high-risk gene group had No ROI or ROI-ROI connection strength was more 
significant than the low-risk gene group at the significant threshold. 
 
Table 6: Gene Group ROI 
ROI  Area Stats Intensity size P-unc value 
P-FDR 
value 
85 Precuneus  F(8)(28) = 13.93 81.90 10 0.0000 0.0000 
17L (L). Primary Visual Cortex F(8)(28) = 13.37 62.39 7 0.0000 0.0000 
29R (R) Retrosplenial Cingulate Cortex F(8)(28)= 12.99 54.51 6 0.0000 0.0000 
29L (L) Retrosplenial Cingulate Cortex F(8)(28)= 12.51 45.54 5 0.0000 0.0000 
18R (R) Secondary Visual Cortex F(8)(28) = 12.32 86.47 11 0.0000 0.0000 
18L (L) Secondary Visual Cortex F(8)(28) = 11.86 88.28 11 0.0000 0.0000 
17R (R) Primary Visual Cortex F(8)(28)= 11.27 81.99 11 0.0000 0.0000 
The More Significantly Connected Regions W/o ApoE4 vs. ApoE4 Carriers. In this 
table we only included ROI that were more significantly connected at a .00001 two-sided 
FDR-p value. 
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Table 7: Gene Group Connections 
ROI Area Strength P-unc value 
P-FDR 
value 
29R-29L (R). Retrosplenial Cingulate Cortex -(L). Retrosplenial Cingulate Cortex T(35) = 12.38 0.0000 0.0000 
18L-17L (L). Secondary Visual Cortex-(L). Primary Visual Cortex T(35) = 12.05 0.0000 0.0000 
18L-19L (L). Secondary Visual Cortex-(L). Associative Visual Cortex T(35) = 11.64 0.0000 0.0000 
17R-18R (R). Primary Visual Cortex- (R). Secondary Visual Cortex T(35) = 10.80 0.0000 0.0000 
19R-18R (R). Associative Visual Cortex -(R). Secondary Visual Cortex T(35) = 10.53 0.0000 0.0000 
17R-19R (R). Primary Visual Cortex-(R). Associative Visual Cortex T(35) = 10.24 0.0000 0.0000 
18R-18L (R). Secondary Visual Cortex-(L). Secondary Visual Cortex T(35) = 10.18 0.0000 0.0000 
17L-19L (L). Primary Visual Cortex-(L). Associative Visual Cortex T(35) = 10.07 0.0000 0.0000 
17L-17R (L). Primary Visual Cortex- R). Primary Visual Cortex T(35) = 10.06 0.0000 0.0000 
18R-17L (R). Secondary Visual Cortex -(L). Primary Visual Cortex T(35) = 9.88 0.0000 0.0000 
29L-30L (L). Retrosplenial Cingulate Cortex -(L). Cingulate Cortex T(35) = 9.74 0.0000 0.0000 
30L-29R (L). Cingulate Cortex-(R). Retrosplenial Cingulate Cortex T(35) = 9.60 0.0000 0.0000 
23L-85 (L). Ventral Posterior Cingulate Cortex- Precuneus T(35) = 9.44 0.0000 0.0000 
85-23R Precuneus-(R). Ventral Posterior Cingulate Cortex T(35) = 9.07 0.0000 0.0000 
29R-23L (R). Retrosplenial Cingulate Cortex-(L). Ventral Posterior Cingulate Cortex T(35) = 8.83 0.0000 0.0000 
85-31L Precuneus-(L). Dorsal Posterior Cingulate Corte T(35) = 8.80 0.0000 0.0000 
85-29R Precuneus-(R). Retrosplenial Cingulate Cortex T(35) = 8.54 0.0000 0.0000 
29L-23L (L). Retrosplenial Cingulate Cortex- (L). Ventral Posterior Cingulate Cortex T(35) = 8.46 0.0000 0.0000 
18R-19L (R). Secondary Visual Cortex- (L) Associative Visual Cortex T(35) = 8.41 0.0000 0.0000 
17R-19L (R). Primary Visual Cortex -(L) Associative Visual Cortex T(35) = 8.36 0.0000 0.0000 
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18L-17R R). Primary Visual Cortex-(R). Primary Visual Cortex T(35) = 8.93 0.0000 0.0000 
18L-19R (L). Secondary Visual Cortex-(R). Associative Visual Cortex T(35) = 8.53 0.0000 0.0000 
18L-19L (L). Secondary Visual Cortex-(L). Associative Visual Cortex T(35) = 8.41 0.0000 0.0000 
29R-30R (R). Retrosplenial Cingulate Cortex -(R). Cingulate Cortex T(35) = 8.37 0.0000 0.0000 
18L-37L (L). Secondary Visual Cortex-(L). Fusiform gyrus T(35) = 8.21 0.0000 0.0000 
17L-19R (L). Primary Visual Cortex- (R) Associative Visual Cortex T(35) = 8.20 0.0000 0.0000 
29L-85 (L). Retrosplenial Cingulate Cortex- Precuneus T(35) = 8.14 0.0000 0.0000 
31R-85 (R). Dorsal Posterior Cingulate Cortex-Precuneus T(35) = 7.76 0.0000 0.0000 
30L-85 (L). Cingulate Cortex- Precuneus T(35) = 7.51 0.0000 0.0000 
The More Significant ROI-ROI connections in W/o ApoE4  vs. ApoE4 Carrier. In 
this table we only included ROI-ROI connections that were more significantly connected 
at a .00001 two-sided FDR-p value. 
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Figure 5: Superior, Inferior, Right, Left, Anterior View W/o ApoE4 > ApoE4 
Connectivity: Significant ROI, and ROI-ROI connection in with ApoE4 allele or without 
ApoE4 allele subject groups.  Red to green = more to less significant. 
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Figure 6: 2D Axial ROI-Labeled, w/o ApoE4 > w/ApoE4 Connectivity: Significant 
ROI, and ROI-ROI connection in with E4 ApoE allele or without ApoE4 allele subject 
groups.  Red to green = more to less significant. 
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Gene Group vs. Subject Group 
There were significant differences in brain connectivity between subjects with 
variance in ApoE expression, and who were in the control and EMCI groups.  Subjects 
who were in low risk gene group and control, had stronger ROI connectivity in 3 ROI 
(see table 11). Low-risk gene individuals who were in the control group had 21 
significantly stronger ROI-ROI specific connections (see table 12). The subjects in the 
high-risk gene group also with EMCI had No ROI or ROI-ROI connection strength was 
more significant than the low-risk gene group at the significant threshold. 
 
Table 8: Subject Group v. Gene Group ROI 
ROI  Area Stats Intensity size P value 
85 Precuneus X(24) = 75.62 327.83 10 0.0000 
17L (L). Primary Visual Cortex X(24) = 75.46 364.42 6 0.0000 
18R (R). Inferior Temporal Gyrus X(24) = 73.87 336.64 7 0.0000 
The More Significantly Connected Regions in W/o ApoE4 and Normal subjects vs. 
ApoE4 Carriers and EMCI subjects. In this table we only included ROI that were more 
significantly connected at a .00001 two-sided FDR-p value. 
Group v. Gene Connection  
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Table 9: Subject Group v. Gene Group Connections 
ROI Area Strength P-unc value 
p-FDR 
value 
17L-18L L Primary Visual Cortex- L Secondary Visual Cortex F(3)(33) = 121.13 0.0000 0.0000 
17R-18R R Primary Visual Cortex- R Secondary Visual Cortex F(3)(33) = 74.50 0.0000 0.0000 
18R-18L R &L Secondary Visual Cortex F(3)(33) = 70.84 0.0000 0.0000 
17L-17R L Primary Visual Cortex –  R Primary Visual Cortex F(3)(33) = 67.26 0.0000 0.0000 
17L -18R  L Primary Visual Cortex- R Secondary Visual Cortex F(3)(33) = 65.19 0.0000 0.0000 
17L-19R L Primary Visual Cortex- R Associative Visual Cortex F(3)(33) = 59.09 0.0000 0.0000 
18R-19R R Secondary Visual Cortex- R Associative Visual Cortex F(3)(33) = 50.44 0.0000 0.0000 
85-PCC Precuneus- Posterior Cingulate Cortex F(3)(33) = 46.63 0.0000 0.0000 
85-29R PCC- R Retrosplenial Cingulate Cortex F(3)(33) = 41.94 0.0000 0.0000 
85-31L PCC-L Dorsal Posterior Cingulate Cortex F(3)(33) = 37.46 0.0000 0.0000 
85-31R PCC- R Dorsal Posterior Cingulate Cortex F(3)(33) = 37.21 0.0000 0.0000 
85-23L PCC-(L). Ventral Posterior Cingulate Cortex F(3)(33) = 36.08 0.0000 0.0000 
85-23R PCC- (R). Ventral Posterior Cingulate Cortex F(3)(33) = 31.14 0.0000 0.0000 
31L-PCC L Dorsal Posterior Cingulate Cortex-PCC F(3)(33) = 30.81 0.0000 0.0000 
17L-19R L Primary Visual Cortex - R Associative Visual Cortex F(3)(33) = 29.91 0.0000 0.0000 
85-7L PCC-(L). Somatosensory Association F(3)(33) = 24.89 0.0000 0.0000 
18R-37R R Secondary Visual Cortex-(R). Fusiform gyrus F(3)(33) = 23.82 0.0000 0.0000 
85-30L PCC-L Cingulate Cortex F(3)(33) = 22.30 0.0000 0.0000 
17L-37L L Primary Visual Cortex-(L). Fusiform gyrus F(3)(33) = 21.85 0.0000 0.0000 
85-30R PCC- R Cingulate Cortex F(3)(33) = 19.39 0.0000 0.0000 
18R-39R R Secondary Visual Cortex-(R). Angular gyrus F(3)(33) = 15.66 0.0000 0.0000 
The More Significant ROI-ROI connections in W/o ApoE4 and Normal Subjects vs. 
ApoE4 Carrier and EMCI Subjects. In this table we only included ROI-ROI 
connections that were more significantly connected at a .00001 two-sided FDR-p value. 
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Figure 7: Superior, Inferior, Right, Left, Anterior View W/o ApoE4 > ApoE4 X 
Normal > EMCI Connectivity: Significant ROI, and ROI-ROI Connection in Control 
versus EMCI subject groups plus with ApoE4 allele or without ApoE4 allele subject 
groups.  Red to green = more to less significant. 
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Figure 8: 2D Axial ROI-Labeled W/o ApoE4 > ApoE4 X Normal > EMCI 
Connectivity: Significant ROI, and ROI-ROI Connection in Control versus EMCI 
subject groups plus with ApoE4 allele or without ApoE4 allele subject groups.  Red to 
green = more to less significant. 
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DISCUSSION 
Comparison of EMCI Versus Control Subject 
Group Network Connectivity Differences 
We found significant differences in the functional architecture of the healthy 
aging brain and the EMCI brain at rest.  The EMCI brain had decreased RS-FC strength 
in many ROIs, but most notably: the visual cortices, the associative visual cortices, the 
right inferior temporal gyrus, the left secondary visual cortex, the precuneus, the right 
retrosplenial cingulate cortex, the left dorsal posterior cingulate cortex and the left dorsal 
anterior cingulate cortex (see table 7).  These decreases in ROI connectivity strength 
reflect the decrease in activity coherence of the ROI (Whitfield-Gabrieli and Nieto-
Castanon, 2013).  The EMCI brain had decreased activation of 16 ROI-to-ROI 
connections at the .00001 FDR-p threshold level: the visual cortices, the cingulate 
cortices, the precuneus, and the retrosplenial cingulate cortices (see table 8).  
Prefrontal Areas 
The notable difference between the EMCI-based decrease and the ApoE4 
genotype-based decrease in network connectivity, to be discussed in the following 
section, was in the frontal lobe structures.  The EMCI group showed decreased ROI 
strength and connectivity in the left dorsal anterior cingulate cortex and its connections 
with the medial prefrontal cortex (MPFC), anterior prefrontal cortex, right dorsal anterior 
cingulate cortex, and right and left ventral anterior cingulate cortices (see figure 4).  This 
finding suggests that EMCI has some pathology unassociated with genetic predisposition, 
which strongly affects areas in the prefrontal cortex with important memory and 
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cognition functions. MPFC atrophy is specifically associated with memory and decision 
making impairments (Euston et al., 2012). Areas in the cingulate cortex are functionally 
linked to rationally cognitive functions like decision-making, so RS-FC in these areas 
could cause dementia-like cognitive issues (Decety et al., 2004). The prefrontal cortex is 
known to atrophy naturally with old age (Euston et al., 2012). Since the EMCI and 
control groups were age-matched, our findings illustrate how EMCI pathology is more 
significantly affecting the prefrontal lobe regardless of other age-related morphometric 
changes.  This finding further strengthens the idea that AD pathology has multiple 
factors.  This finding also suggests that the frontal lobe connectivity weakness in the 
EMCI subjects is mostly due to factors other than ApoE genetics.   
Cingulate Cortex and Associated Areas 
We found that EMCI subjects had decreased functional connectivity in the 
temporal gyrus, precuneus, retrosplenial cingulate cortices, posterior cingulate cortex 
(PCC) and anterior cingulate cortex, which is consistent with previous research. Buckner 
et al. (2004), showed that AD preferentially affects the medial temporal lobe and cortical 
networks, including the posterior cingulate and retrosplenial cortex early in progression.  
The surrounding hippocampal areas in the medial temporal lobe (MTL) are known to be 
affected by AD pathology and show atrophy in structural analysis, which is consistent 
with our findings of decreased functional activity in the medial temporal gyrus, 
precuneus, dorsal posterior cingulate cortex, dorsal anterior cingulate cortex, and right 
retrosplenial cingulate cortex (Buckner et al., 2004).  
The hippocampus is regarded as the memory center, but it is closely linked both 
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functionally and physically to this other distinct anatomy (Buckner et al., 2004). These 
results suggest that areas other than the hippocampus associated with memory and 
cognition are being affected by EMCI pathology.  The medial frontal lobe and PCC have 
high resting state metabolisms and are thought to be engaged in attending to 
environmental stimuli, planning the future and thinking about the past (Greicius et al., 
2003).  Therefore, it seems reasonable to posit that disruption in their function would 
cause declines in cognitive function (Greicius et al., 2003). The precuneus is closely 
related to the PCC and is involved in episodic memory, working memory, visuospatial 
processing and conscious perception (Buckner 2004). It has been suggested that the 
precuneus decides whether to call upon the hippocampus for cognitive use, and so 
disruption in its functional connectivity could have a high impact on memory (Buckner et 
al., 2009).   Studies of resting state metabolism using PET and SPECT in AD suggest that 
abnormalities in the PCC and precuneus can be an early marker of AD, which is 
consistent with our finding (Bradley et al., 2002).  Using independent component analysis 
(ICA), Greicius et al. (2004) showed that resting-state activity in the PCC and 
hippocampus is deficient in AD. The functionality of these areas suggest that their 
deactivation would lead to the decreased task performance and memory allocation seen in 
EMCI.  Previous results have shown that PCC and medial prefrontal cortex are important 
hub regions in the human brain (Tomasi and Volkow, 2010; Buckner, 2009).  Hub 
regions exchange information with many other regions and largely influence information 
communication and functional integration between functionally separate brain regions 
(Sporns et al., 2011).  Therefore, we would expect the observed functional connectivity 
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abnormalities in the PCC and MPFC hub regions to have wide-spread and significant 
implications. Buckner et al. (2005) hypothesized that the high use of these hub regions in 
daily life could increase the accumulation of amyloid plaques, and result in the observed 
functional abnormalities of EMCI and AD. 
The retrosplenial cortex (RSC), shown in our study to have decreased RS-FC, is a 
key member in the network of brain regions that underlies episodic memory, navigation, 
and planning for the future, and is consistently compromised in the neurological disorders 
that impair memory (Vann et al., 2009). The retrosplenial cortex is situated at the 
crossroads between the hippocampal formation and many areas of the neocortex (Vann et 
al., 2009).  Therefore, its decrease in function observed in the EMCI subjects could cause 
widespread and significant memory processing issues. It has been speculated that the 
retrosplenial cortex acts as an interface zone between working memory functions enabled 
by the prefrontal cortex and long-term memory functions of the medial temporal lobe 
memory system (Kobayashi and Amaral, 2003). Combining these facts with the current 
finding, the decreased connectivity around the hippocampus in the PCC, cingulate 
cortices, precuneus, MTL, and retrosplenial cortices may exhibit the decreased activity of 
memory retrieval and function that is described in EMCI.   
Histological studies have found these brain regions to have cellular atrophy, 
pathology and death and the accumulation of tau proteins changes with AD pathology 
(Buckner et al., 2004; Rombouts et al., 2005).  AD pathology is characterized by 
neurofibrillary tangles (NFTs), amyloid aggregations and a loss of cortical neurons and 
synapses (Hirano, 1962).  NFTs affect the specific cortical layers in the hippocampus that 
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serve as pathways from the hippocampus to the rest of the brain (Hirano, 1962).  These 
pathological lesions developed in AD and EMCI could isolate the hippocampus from the 
rest of the brain and lead to the observed functional connectivity abnormalities in the 
brain regions linked to the hippocampus (Hirano, 1962). The present study extends the 
previous histological and structural studies by showing decreased functional connectivity 
in the same areas (Buckner et al., 2004).   
Visual networks 
In EMCI subjects there was also disruption of the network connectivity in the 
primary, secondary and associative visual cortices (see tables 4 and 5).  The visual cortex 
areas are associated with the repository of long-term visual memory, and non-specific 
mental imagery (Miyashita, 1993; Kosslyn, 2001). Consequently, the reduced 
connectivity in these non-specific regions in EMCI subjects may be a contributing factor 
to their memory impairment (Buckner and Wheeler, 2001). Wang et al. (2006) 
demonstrated disrupted connectivity between the hippocampus and higher-order visual 
cortices in early AD, which is consistent with our findings. Buckner and Wheeler (2001) 
had similar findings, and proposed that the retrieval of visual information from episodic 
long-term memory is fulfilled by neural interactions between the medial temporal lobe 
structures and the posterior neocortex like the occipital sulcus.  The functional 
disconnection between the more primary ‘memory centers’ in the brain like the PCC and 
less specific memory centers like the visual cortices could be a reflection of the 
breakdown of hippocampal and medial temporal lobe-related cortical networks in early 
dementia.   
	  	   36 
DMN 
It is also important to point out that a number of the areas of decrease in nodal 
strength in the EMCI subjects are a part of the default mode network (DMN).  The DMN 
is a task-negative network that is most active during wakeful rest, and includes the MTL, 
MPFC, PCC, precuneus and the medial, lateral and inferior parietal cortex (Greicius et 
al., 2004).  The specific function of the DMN is still unclear, but the network is thought 
to be related to self-referential thought, daydreaming and memory recall (Greicius et al., 
2004). The documented decline of nodal strength in the DMN of EMCI subjects in our 
study is consistent with previous studies and suggests memory-related deficits in EMCI 
cognitive ability are linked to disrupted DMN function (Zong et al., 2014; Greicius et al., 
2004).  
Disconnection syndrome 
Overall, these findings support the theory that AD is a disconnection syndrome 
and that AD results from loss of normal connectivity between neuronal systems 
beginning with the isolation of the hippocampal formation (Delbeuk et al., 2003).  
Previous studies have suggested that AD not only affects regional anatomy but the 
functional integration of brain regions (Liu, 2014). The disruption of neural input and 
output of the hippocampus could manifest as a change in functional connectivity in the 
surrounding areas.   Decreased resting state connectivity was shown in EMCI subjects 
between a variety of cortical regions that have important connections with the 
hippocampus including the retrosplenial cingulate cortex, precuneus, posterior cingulate 
cortex and visual areas.   
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Comparison of ApoE Genotype Group Network Connectivity Differences 
We found significant decreases in the RS-FC strength in the APOE4 genotype 
group.  At rest, the E4 carriers showed the most significant decreased functional ROI 
activation in the precuneus, primary visual cortex, retrosplenial cingulate cortices, 
secondary visual cortices and primary visual cortex (see table 6). The measured ROI RS-
FC strength decrease was a reflection of the decrease in activity coherence of the ROI 
(Whitfield-Gabrieli and Nieto-Castanon, 2013).  The E4 carrier showed the most 
significant decrease in functional connectivity between ROIs in the retrosplenial 
cingulate cortices, visual cortices, cingulate cortices and precuneus (see table 7). The 
FDR-p value threshold was set to .00001 to test for only the most significant changes 
(See tables 6 and 7). We interpreted these results as the manifestation of an intrinsic 
effect of ApoE on the differentiation of functional cortical networks.   
The ApoE4 allele is the best-known genetic risk factor for sporadic AD, and it 
increases the risk of developing AD 3 to 15 times (Mahley, 2006).  At the cellular level, 
ApoE is important for creating healthy connections between neurons and communicating 
between brain regions and there is evidence that ApoE plays a crucial isoform dependent 
role in neurodevelopment (Wright et al., 2003).  Specifically, the development of mature 
synapses depends on ApoE secretion and cholesterol from glial cells (Mauch et al., 
2001).  ApoE4’s negative affect has been shown at the microscale to inhibit neurite 
growth in in-vitro studies (Nathan et al., 1995). On the macroscale, the specific effects of 
ApoE4 on brain function and network connectivity is not yet clear.  ApoE genotype could 
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contribute to differences in developing AD, most likely through its pathology interacting 
with AD-specific neurodegeneration. 
 
Prefrontal Areas 
As discussed above, the notable difference between ApoE4 genotype-decrease 
and the EMCI-based decrease in network function and connectivity was in the prefrontal 
lobe structures. The ApoE4 group did not show disrupted network function in the frontal 
lobe structures of the left dorsal anterior cingulate cortex and its connections with the 
MPFC, anterior prefrontal cortex, right dorsal anterior cingulate cortex, and right and left 
ventral anterior cingulate cortices, observed in the EMCI group (see figure 5). This 
finding suggests that ApoE4 pathology is an independent and contributing factor to 
EMCI pathology. Due to the fact that the ApoE4 allele is the best-known genetic risk 
factor for AD, the ApoE4-related changes in RS-FC may be a better indicator of AD 
pathology than the prefrontal lobe changes documented in the EMCI subjects (Mahley et 
al., 2006).  The prefrontal cortex is known to atrophy naturally with age, and prefrontal 
cortex RS-FC weakness could be an effect of natural age-related morphometry instead of 
genetic factors (Euston et al., 2012). Our findings suggest that prefrontal lobe 
connectivity weakness could be a symptom that separates EMCI individuals into those 
with more natural aging-related memory loss versus genetic ApoE4-related memory loss. 
EMCI is the earliest form of dementia and not all EMC diagnosed patients develop AD 
(Petersen et al., 2001). Patients with EMCI who have more disrupted frontal lobe RS-FC 
could have a unique pathology, with a different risk probability of developing AD.  
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Cingulate Cortex and Associated Areas 
Similar to the EMCI group, the ApoE4 group had decreased RS-FC in the 
cingulate cortices and surrounding hippocampal areas: the precuneus, retrosplenial 
cingulate cortices, cingulate cortices, ventral posterior cingulate cortices, dorsal posterior 
cingulate cortices, and fusiform gyrus (see table 6 and 7). The similarity of affected ROI 
between the EMCI and ApoE4 groups shows the possible strong effect of ApoE4 on 
EMCI pathology.  
Filippini et al. (2009), found ApoE genotype to alter RS-FC between 
hippocampal, medial prefrontal, and retrosplenial regions of the brain in the DMN in E4 
carriers relative to non-carriers, consistent with our findings.  Other groups have found an 
effect of the E4 allele on the functional connectivity between the PCC and precuneus and 
a number of frontal, parietal and medial temporal regions (Fleisher et al., 2009; Sheline et 
al., 2010).  The differences in functional connectivity between ApoE genotype groups 
could be due to the allele’s developmental maintenance of well-defined cortical networks. 
Since both EMCI and the ApoE4 gene were shown to affect similar brain areas, the 
decrease in RS-FC in the brains of E4 carriers could interfere with the ability of this 
group to cope with increasing levels of AD pathology in the same areas.  EMCI patients 
without the E4 allele appear to show similar changes in brain function with age, but have 
a reduced risk of developing AD.  Sheline et al. (2010) reported that there were 
differences between healthy control E4 carriers and non-carriers.  The authors also 
pointed out that the brain regions influenced by ApoE4 in healthy controls overlapped 
with the regions we found to be associated with EMCI.  This same research later used 
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Compound-B PET imaging to show that none of their healthy participants had amyloid 
plaque build-up, indicating that the functional changes were directly related to ApoE4 
and not AD pathology (Sheline et al., 2010).   
Visual Areas 
Similar to the EMCI group, the ApoE4 group had decreased RS-FC in the 
primary, secondary and associative visual cortices (see table 6 and 7). As discussed 
above, the visual cortex areas are associated with mental imagery and memory recall 
(Buckner and Wheeler, 2001). Trachtenberg et al. (2012b) found that E4 carrier groups 
had decreased connectivity in the primary visual cortex similar to our results. The 
dysfunction in these secondary memory regions in ApoE4 subjects could contribute to the 
cognitive impairment associated with AD pathology. The ApoE4 groups’ weakness in 
RS-FC between both the more primary ‘memory center’ ROI in the brain like the 
cingulate cortex, precuneus and less specific memory center ROI like the visual cortices 
could be a reflection of how complex ApoE4 pathology is, and the role of this gene on 
brain development.  As theorized above, the decrease in RS-FC in the brains of E4 
carriers could interfere with the ability of this group to cope with increasing levels of AD 
pathology in the same areas.   
The results observed here, especially in parallel to the EMCI group findings, can 
provide insight into the relationship between ApoE genotype, brain function and AD risk.  
The similar but not identical pattern of disconnectivity and weakness in functional 
connectivity between the EMCI and ApoE4 groups suggests that the pathology is similar 
but EMCI pathology is more multidimensional. Highlighting the differences between the 
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EMCI and ApoE4 genetically-linked pathologies can illustrate how EMCI phenotypes 
differ, and how ApoE genotype could predispose people to the disease.  
Comparison of Subject Groups’ Versus ApoE Genotype  
Groups’ Network Connectivity Differences 
We found significant differences in RS-FC by comparing the subject groups to the 
ApoE genotype groups.  The EMCI subjects who were E4 carriers showed the most 
decrease in ROI functional connectivity strength of the precuneus, primary visual cortex, 
and inferior temporal gyrus (see table 8). This measurement in decreased ROI 
connectivity strength reflects the decrease in activity coherence of the ROI (Whitfield-
Gabrieli and Nieto-Castanon, 2013). The EMCI subjects who were E4 carriers showed 
RS-FC decrease of 21 ROI-to-ROI connections at the .00001 FDR-p threshold level 
between the visual cortices, PCC, retrosplenial cingulate cortices, cingulate cortices, 
precuneus and fusiform gyrus (see table 9). This multi-group analysis was able to 
reaffirm the previous findings from between-group analysis that RS-FC dysfunction 
occurs most strongly in EMCI subjects, and in those with the ApoE4 genotype.  The 
EMCI subject group as a whole, containing all the ApoE genotypes, showed decreased 
RS-FC predominantly in the prefrontal lobe, cingulate cortices and surrounding 
hippocampal areas when compared to controls. Therefore, this analysis further shows that 
within the EMCI group the greatest dysfunction in RS-FC is happening in those with the 
ApoE4 genotype and most strongly affecting only the precuneus, primary visual cortex 
and inferior temporal gyrus. As discussed above, these ROIs are all important areas for 
memory and cognition.  The precuneus is involved with episodic memory, while the 
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inferior temporal gyrus is associated with semantic memory and the primary visual cortex 
functions in working memory.   
These findings show that although the EMCI E4 carrier group showed only a few 
ROI with total RS-FC strength decrease, they showed dysfunction in connectivity 
between 21 ROIs (see figure 7 and 8). This finding highlights that within this EMCI 
ApoE4 population the greatest RS-FC disturbance is happening in the individual 
connections between ROIs, versus in the strength of ROIs. This population may have a 
unique dementia pathology that affects connectivity between specific areas with memory 
and cognition functions (see table 8). Where as, EMCI subjects with a variety of APOE 
genotypes may have a greater variety of RS-FC dysfunction that includes the prefrontal 
lobe and other MTL structures, but doesn’t affect individual connectivity between ROI as 
strongly.  The similar, but not identical pattern of disconnectivity and weakness in RS-FC 
between the ApoE4 group and the EMCI ApoE4 group suggests that ApoE4 affects both 
normal aging and EMCI subjects similarly but that EMCI is unique.  The distinct pattern 
of RS-FC dysfunction in the EMCI ApoE4 group is highlighting how ApoE4 pathology 
is interacting with other EMCI factors to create a specific EMCI phenotype that 
predominantly has weak connectivity between a number of important ROIs including the 
visual cortices, PCC, retrosplenial cingulate cortices, cingulate cortices, precuneus and 
fusiform gyrus (see table 8).  As discussed above, all of these cortical areas have 
important roles in memory and cognition. 
Several studies have used fMRI to study the effects of ApoE on brain function, 
but most have only studied normal populations and only in specific RSN or brain areas. 
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This final multi-group analysis shows a novel finding by investigating the effect of ApoE 
genotype on a control, EMCI and mixed subjects pool. The results from this analysis are 
particularly robust because we did not restrict the ROI analysis, and the results show 
whole-brain analysis findings. Also, these results have very high statistical significance 
because they were set at a .00001 FDR-p value threshold as to only obtain the greatest 
changes in RS-FC.  
CONCLUSION 
 
Our results show that there are distinct difference in RS-FC between EMCI and 
normal aging subjects, between ApoE4 carrier and non-carriers, and between EMCI 
ApoE4 carrier subjects and EMCI non-carriers subjects.  As expected from previous 
research, ROI RS-FC network properties were disrupted in EMCI. Our results 
highlighted the decrease in EMCI RS-FC in the visual cortices, temporal gyrus, the 
precuneus, the retrosplenial cingulate cortices, the PCC, MPFC and the anterior cingulate 
cortices. There was a strong overlap in the areas that showed a decrease in RS-FC in the 
EMCI group and the ApoE4 genotype group, suggesting that ApoE4 plays a strong role 
in developing EMCI either directly or through interaction with other pathology. We 
found that only the EMCI group had a decrease in RS-FC of the prefrontal cortex areas.  
This suggests that EMCI pathology is more multi-dimensional than the APOE4 genetic 
AD predisposition alone, and EMCI pathology could combine natural aging prefrontal 
lobe atrophy. Not surprisingly, the EMCI E4 carrier group showed the most RS-FC 
dysfunction and greatest decrease in ROI strength and connectivity. Interestingly this 
EMCI E4 carrier group showed RS-FC decreases predominantly in the individual 
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connections between ROI, versus in the strength of ROIs.  Therefore, this population may 
have a unique dementia pathology that mostly affects connectivity between specific areas 
with memory and cognition functions.  
Previous research has used fMRI to study the effects of ApoE on brain function, 
but none have used matched EMCI and control subjects to look at the ApoE effect on 
each group and the subjects as a whole. Also, few groups have used whole-brain ROI-to-
ROI analysis to investigate the broad impact of both EMCI and ApoE on the RS-FC of 
the brain. By using this type of analysis we provided evidence that EMCI is a disease 
with multiple factors, and that ApoE4 genotype has a similar and most likely contributing 
pathology.  We also show that the ApoE genetic affect on RS-FC is similar across healthy 
controls and EMCI subjects.  This opens up the investigation of what other factors 
interact with ApoE to cause EMCI.  
When considering the size and generalizability of the study in comparison to 
relation to prior studies using rsfMRI to explore stages of AD, this study had an average 
sample size. The 55 prior studies published in the past 2 years on this topic used a median 
total sample of 37 subjects (Delbeuck et al., 2003). Our sample was composed of N 38 
subjects, which although not large in absolute terms, is comparable to previous literature.  
Therefore, our results seem to be generalizable. I would propose future research to use 
larger sample sizes, which would be able to breakdown the ApoE genotype more 
specifically than with or without ApoE4 allele groups.  This more specific ApoE analysis 
could reveal more detailed information on how each ApoE genotype affects EMCI and its 
unique RS-FC. 
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